BTAI |
BioXcel Therapeutics, Inc. |
Sep 17, 2024 |
2 |
-$3.95K |
4 |
Oct 3, 2024 |
Chief Financial Officer |
BTAI |
BioXcel Therapeutics, Inc. |
Sep 14, 2024 |
5 |
-$246 |
4 |
Sep 17, 2024 |
Chief Financial Officer |
ATOS |
ATOSSA THERAPEUTICS, INC. |
Jun 27, 2024 |
1 |
$0 |
4 |
Jul 1, 2024 |
Director |
BTAI |
BioXcel Therapeutics, Inc. |
Jun 14, 2024 |
5 |
-$470 |
4 |
Jun 18, 2024 |
Chief Financial Officer |
BTAI |
BioXcel Therapeutics, Inc. |
Mar 14, 2024 |
5 |
-$2.82K |
4 |
Apr 8, 2024 |
Chief Financial Officer |
ATNM |
Actinium Pharmaceuticals, Inc. |
Dec 28, 2023 |
1 |
$0 |
4 |
Dec 29, 2023 |
Director |
BTAI |
BioXcel Therapeutics, Inc. |
Dec 14, 2023 |
2 |
$0 |
4 |
Dec 18, 2023 |
Chief Financial Officer |
BTAI |
BioXcel Therapeutics, Inc. |
Sep 14, 2023 |
2 |
$0 |
4 |
Sep 18, 2023 |
Chief Financial Officer |
BTAI |
BioXcel Therapeutics, Inc. |
Jun 14, 2023 |
2 |
$0 |
4 |
Jun 16, 2023 |
Chief Financial Officer |
BTAI |
BioXcel Therapeutics, Inc. |
May 14, 2023 |
3 |
-$136K |
4 |
May 16, 2023 |
Chief Financial Officer |
ATOS |
ATOSSA THERAPEUTICS, INC. |
May 4, 2023 |
1 |
$0 |
4 |
May 5, 2023 |
Director |
BTAI |
BioXcel Therapeutics, Inc. |
Mar 14, 2023 |
5 |
-$40.6K |
4 |
Mar 16, 2023 |
Chief Financial Officer |
ATNM |
Actinium Pharmaceuticals, Inc. |
Jul 1, 2022 |
1 |
$0 |
4 |
Jul 1, 2022 |
Director |
BTAI |
BioXcel Therapeutics, Inc. |
May 14, 2022 |
1 |
$0 |
4 |
May 17, 2022 |
Senior VP and CFO |
ATOS |
ATOSSA THERAPEUTICS, INC. |
May 13, 2022 |
1 |
$0 |
4 |
May 16, 2022 |
Director |
BTAI |
BioXcel Therapeutics, Inc. |
Mar 14, 2022 |
2 |
$0 |
4 |
Mar 16, 2022 |
Chief Financial Officer |
ATNM |
Actinium Pharmaceuticals, Inc. |
Sep 1, 2021 |
1 |
$0 |
4 |
Sep 3, 2021 |
Director |
ATOS |
ATOSSA THERAPEUTICS, INC. |
May 14, 2021 |
1 |
$0 |
4 |
May 18, 2021 |
Director |